FDA Approves Bonsity (teriparatide injection) to Treat Osteoporosis

Article Link: FDA Approves Bonsity (teriparatide injection) to Treat Osteoporosis

SAN DIEGO, October 7, 2019 — Pfenex Inc. (NYSE American: PFNX) announced today that the U.S. Food and Drug Administration (FDA) has approved the new drug application (“NDA”) for Bonsity (PF708) submitted under the 505(b)(2)…

Source: FDA New Drug Approvals